Silver Economy Fund has acquired 100% of MIR - Medical International Research, aiming to enhance its growth in the spirometry market amid rising demand for respiratory health products.

Target Company Overview

On January 29, 2025, the Silver Economy Fund acquired 100% of MIR - Medical International Research, a leading company in the field of spirometry. The shares were purchased from previous shareholders, including Aksia SGR S.p.A., Overseas Industries, Giovanni Carlino, founder Siro Brugnoli, and the management team. This acquisition was executed alongside a group of co-investors: Turenne Santè, using its new equity fund Capital Santè 3, as well as Eurazeo through its Nov Santé Actions Non Cotées fund, BNP Paribas BNL Equity Investments S.p.A., Entheos S.A.S., and Muzinich & Co. Roberta Di Pinto and Adriano Mencarini, newly appointed CEO and CTO of MIR, will reinvest in the company, thus remaining part of the ownership structure.

MIR, founded in Rome in 1993, is a global leader in the spirometry sector, catering to both professional and personal use. The company promotes early diagnosis and monitoring of major respiratory conditions and offers an integrated diagnostic platform that includes medical devices (such as pulse oximeters, spirometers, and single-use respiratory turbines) and proprietary software for real-time monitoring of vital signs.

Industry Overview

In Italy, the spirometry market is valued at over one billion euros and is on a growth trajectory that is projected to reach 1.8 billion euros by 2031. This growth can be attributed to an increasing focus on respiratory